Home
/
Opus Genetics, Inc.
/
Financials
/
Quarterly
Opus Genetics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Opus Genetics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Sep 30, 2020
$1.15M
Oct 29, 2020
Q2
2020
Jun 30, 2020
$1.15M
Aug 14, 2020
Q1
2020
Mar 31, 2020
$1.15M
May 7, 2020
Q1
2014
Mar 31, 2014
$0
May 14, 2014
Q3
2013
Sep 30, 2013
$0
Nov 13, 2013
Q2
2013
Jun 30, 2013
$0
Aug 12, 2013
Q1
2014
Mar 31, 2013
$0
May 14, 2014
Q3
2013
Sep 30, 2012
$0
Nov 13, 2013
Q2
2013
Jun 30, 2012
$0
Aug 12, 2013
Q1
2012
Mar 31, 2012
$0
May 9, 2012
Q3
2011
Sep 30, 2011
$0
Nov 9, 2011
Q2
2012
Jun 30, 2011
$0
Aug 8, 2012
Q1
2012
Mar 31, 2011
$0
May 9, 2012
Q3
2011
Sep 30, 2010
$0
Nov 9, 2011
Q2
2011
Jun 30, 2010
$18.8K
Aug 9, 2011
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.08M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$2.88M
Aug 13, 2025
Q1
2025
Mar 31, 2025
$4.37M
May 15, 2025
Q3
2025
Sep 30, 2024
$3.87M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$1.11M
Aug 13, 2025
Q1
2025
Mar 31, 2024
$1.71M
May 15, 2025
Q3
2024
Sep 30, 2023
$11.94M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$3.67M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$1.75M
May 10, 2024
Q3
2023
Sep 30, 2022
$0
Nov 13, 2023
Q2
2023
Jun 30, 2022
$0
Aug 11, 2023
Q1
2023
Mar 31, 2022
$0
May 15, 2023
Q3
2022
Sep 30, 2021
$489.0K
Nov 4, 2022
Q2
2022
Jun 30, 2021
$100.0K
Aug 12, 2022
Q3
2021
Sep 30, 2020
$0
Nov 12, 2021
Q2
2021
Jun 30, 2020
$0
Aug 12, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.45M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($7.42M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($7.42M)
Aug 13, 2025
Q2
2025
Mar 31, 2025
($8.19M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($8.19M)
May 15, 2025
Q3
2025
Mar 31, 2025
($8.19M)
Nov 12, 2025
Q3
2025
Sep 30, 2024
($7.53M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($7.77M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($7.77M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($7.11M)
May 15, 2025
Q2
2025
Mar 31, 2024
($7.11M)
Aug 13, 2025
Q3
2025
Mar 31, 2024
($7.11M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
$5.56M
Nov 12, 2024
Q3
2024
Jun 30, 2023
($4.96M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($4.96M)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($5.79M)
Nov 12, 2024
Q2
2024
Mar 31, 2023
($5.79M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($5.79M)
May 10, 2024
Q3
2023
Sep 30, 2022
($4.53M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($4.93M)
Aug 11, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.31M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($8.91M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($9.93M)
May 15, 2025
Q3
2025
Sep 30, 2024
($8.01M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($8.33M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($7.71M)
May 15, 2025
Q3
2024
Sep 30, 2023
$6.39M
Nov 12, 2024
Q2
2024
Jun 30, 2023
($5.39M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($6.13M)
May 10, 2024
Q3
2023
Sep 30, 2022
($4.54M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($4.94M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($6.51M)
May 15, 2023
Q3
2022
Sep 30, 2021
($4.23M)
Nov 4, 2022
Q2
2022
Jun 30, 2021
($7.14M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($5.19M)
May 13, 2022
Q3
2021
Sep 30, 2020
($1.95M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($1.26M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($2.74M)
May 7, 2021
Q3
2020
Sep 30, 2019
($2.28M)
Oct 29, 2020
Q2
2020
Jun 30, 2019
($2.99M)
Aug 14, 2020